Prof Michael Michael is a consultant Gastrointestinal and Neuroendocrine medical oncologist at the Peter MacCallum Cancer Centre. He has strong academic interest in novel combined modality therapies in these cancers. He also has a significant track record in clinical pharmacology/pharmacogenomics, with a focus on individualising systemic therapy dosing and toxicity prediction.